LBA5 Zongertinib in patients with HER2-mutant NSCLC: Updated analysis of beamion LUNG-1
2024 · Annals of Oncology · 4 citations
https://doi.org/10.1016/j.annonc.2024.10.642
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
9
Papers
19
Citations
2
h-index
0
i10-index
J. Heymach is an academic researcher from The University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & HER2/EGFR in Cancer Research & Monoclonal and Polyclonal Antibodies Research. The author has an h-index of 2, co-authored 8 publications.
https://doi.org/10.1016/j.annonc.2024.10.642
https://doi.org/10.1016/j.annonc.2025.09.088
Click to start Chat